Citations (305)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (20)
Hangdi Xu, Yanjie Hu, Xiuming Peng & Enguo Chen. (2024) Prediction of prognostic and immune therapy response in lung adenocarcinoma based on MHC-I-related genes. Immunopharmacology and Immunotoxicology 46:1, pages 93-106.
Read now
Read now
Susmita Aryal, Sanghyo Park, Hyungkyu Park, Chaewon Park, Woo Cheol Kim, Deepika Thakur, Young-Joo Won & Jaehong Key. (2023) Clinical Trials for Oral, Inhaled and Intravenous Drug Delivery System for Lung Cancer and Emerging Nanomedicine-Based Approaches. International Journal of Nanomedicine 18, pages 7865-7888.
Read now
Read now
Yange Gong, Hongyan Pang, Zhiqiang Yu, Xue Wang, Ping Li & Qianyun Zhang. (2023) Construction of inflammatory associated risk gene prognostic model of NSCLC and its correlation with chemotherapy sensitivity. Annals of Medicine 55:1.
Read now
Read now
Millie Das, Sarika Ogale, Nick Jovanoski, Ann Johnson, Caroline Nguyen, Jan Bhagwakar & Janet S Lee. (2023) Cost–effectiveness of Adjuvant Atezolizumab for Patients with Stage II–IIIA PD-L1+ Non-Small-Cell Lung Cancer. Immunotherapy 15:8, pages 573-581.
Read now
Read now
Shuangqing Chen, Shicheng Liu, Lingxin Kong, Dahu Ren, Zhonghui Hu, Wenbo Wu & Guochen Duan. (2023) Prognostic Significance of Memorial Sloan–Kettering Prognostic Score in Small-Cell Lung Cancer Patients. Biomarkers in Medicine 17:7, pages 391-401.
Read now
Read now
Fatma Yağmur Evcil, Özgür Önal & Emine Elif Özkan. (2023) The Effect of Body Mass Index on Survival in Lung Cancer. Nutrition and Cancer 75:3, pages 857-866.
Read now
Read now
Tinghang Ma, Hui Miao, Yongzhong Xiong, Yu Ma & Zhen Dong. (2023) CircRNA circ-PDCD11 is highly expressed in lung large-cell carcinoma and predicts poor survival. Immunopharmacology and Immunotoxicology 45:1, pages 89-93.
Read now
Read now
Jay M Lee, Rongrong Wang, Ann Johnson, Sarika Ogale, Matthew Kent & Janet S Lee. (2023) Real-world adjuvant chemotherapy patterns and outcomes among elderly patients with resected early non-small-cell lung cancer in the USA. Future Oncology 19:1, pages 37-47.
Read now
Read now
Liu Liu, Yan Wei, Yue Teng, Juntao Yan, Fuming Li & Yingyao Chen. (2022) Health-Related Quality of Life and Utility Scores of Lung Cancer Patients Treated with Traditional Chinese Medicine in China. Patient Preference and Adherence 16, pages 297-306.
Read now
Read now
Hemendra Kumar Sahu, Abhishesh Kumar Mehata, Matte Kasi Viswanadh, Vishnu Priya & Madaswamy S Muthu. (2022) Dual-Receptor-Targeted Nanomedicines: Emerging Trends and Advances in Lung Cancer Therapeutics. Nanomedicine 17:19, pages 1375-1395.
Read now
Read now
Yu Cao, Hong Zhang, Jianming Tang & Rui Wang. (2022) Long non-coding RNA FAM230B is a novel prognostic and diagnostic biomarker for lung adenocarcinoma. Bioengineered 13:3, pages 7919-7925.
Read now
Read now
Bo Zhang, Qida Hu, Jiajie Yu, Junsen Wang, Hanjin Yang, Jiongbo Lou, Guoying Cai, Haifeng Huang, Mengqiu Xu, Zhaoying Xiao & Yun Zhang. (2021) Heterochronous Metastases of Lung Adenocarcinoma to Pancreas and Liver: A Case Report from Pathological Perspectives. OncoTargets and Therapy 14, pages 4269-4273.
Read now
Read now
Sheng Hu, Wenxiong Zhang, Qiang Guo, Jiayue Ye, Deyuan Zhang, Yang Zhang, Weibiao Zeng, Dongliang Yu, Jinhua Peng, Yiping Wei & Jianjun Xu. (2021) Prognosis and Survival Analysis of 922,317 Lung Cancer Patients from the US Based on the Most Recent Data from the SEER Database (April 15, 2021). International Journal of General Medicine 14, pages 9567-9588.
Read now
Read now
Yuanli Huang, Guanghui Zhang, Qing Zhu, Xia Wu & Ligao Wu. (2021) Role of Cytokines Released During Pyroptosis in Non-Small Cell Lung Cancer. Cancer Management and Research 13, pages 7399-7409.
Read now
Read now
Mengjie Yu, Runbin Sun, Yuqing Zhao, Feng Shao, Wei Zhu & Jiye Aa. (2021) Detection and Verification of Coexisting Diagnostic Markers in Plasma and Serum of Patients with Non-Small-Cell Lung Cancer. Future Oncology 17:32, pages 4355-4369.
Read now
Read now
Xabier Mielgo-Rubio, Margarita Martín, Jordi Remon, Oliver Higuera, Virginia Calvo, José Ramón Jarabo, Esther Conde, Javier Luna, Mariano Provencio, Javier De Castro, Fernando López-Ríos, Florentino Hernando-Trancho & Felipe Couñago. (2021) Targeted Therapy Moves to Earlier Stages of Non-Small-Cell Lung Cancer: Emerging Evidence, Controversies and Future Challenges. Future Oncology 17:30, pages 4011-4025.
Read now
Read now
Danilo Rocco, Luigi Della Gravara, Ciro Battiloro & Cesare Gridelli. (2021) The role of nivolumab combined to immunotherapy and/or chemotherapy in the first-line treatment of advanced Non Small Cell Lung Cancer. Expert Opinion on Biological Therapy 21:3, pages 303-309.
Read now
Read now
Virginija Šileikienė, Viktorija Gurskytė, Ingrida Zeleckienė, Elena Bernotienė & Sigitas Čibiras. (2020) Pulmonary artery coil embolisation prevented tumour progression in a patient with advanced squamous cell lung carcinoma. Upsala Journal of Medical Sciences 125:3, pages 257-261.
Read now
Read now
Danilo Rocco, Umberto Malapelle, Marzia Del Re, Luigi Della Gravara, Francesco Pepe, Romano Danesi, Giancarlo Troncone & Cesare Gridelli. (2020) Pharmacodynamics of current and emerging PD-1 and PD-L1 inhibitors for the treatment of non-small cell lung cancer. Expert Opinion on Drug Metabolism & Toxicology 16:2, pages 87-96.
Read now
Read now
Yuanming Cai, Ruxue Jia, Haozhe Xiong, Qun Ren, Weimin Zuo, Tingting Lin, Rong Lin, Yan Lei, Ping Wang, Huiyue Dong, Hu Zhao, Ling Zhu, Yunfeng Fu, Zhiyong Zeng, Wei Zhang & Shuiliang Wang. (2019) Integrative gene expression profiling reveals that dysregulated triple microRNAs confer paclitaxel resistance in non-small cell lung cancer via co-targeting MAPT. Cancer Management and Research 11, pages 7391-7404.
Read now
Read now
Articles from other publishers (285)
Samuele Nicotra, Luca Melan, Federica Pezzuto, Alessandro Bonis, Stefano Silvestrin, Vincenzo Verzeletti, Giorgio Cannone, Alessandro Rebusso, Giovanni Maria Comacchio, Marco Schiavon, Andrea Dell’Amore, Fiorella Calabrese & Federico Rea. (2024) Significance of Spread Through Air Spaces and Vascular Invasion in Early-stage Adenocarcinoma Survival. American Journal of Surgical Pathology 48:5, pages 605-614.
Crossref
Crossref
Zhongyu Qin, Jin Ma, Xu Chu, Taozhen Guo, Pengcheng Feng & Ming Wang. (2024) Delivery of miR-29a improves the permeability of cisplatin by downregulating collagen I expression. Biochemical and Biophysical Research Communications 710, pages 149884.
Crossref
Crossref
Amirhossein Davoodvandi, Reza Asemi, Mehran Sharifi, Russel J. Reiter, Seyed Amirhassan Matini, Seyyed Mehdi Mirhashemi & Zatollah Asemi. (2024) Melatonin as a Promising Agent for Cancer Treatment: Insights into
its Effects on the Wnt/beta-catenin Signaling Pathway. Current Medicinal Chemistry 31:11, pages 1315-1331.
Crossref
Crossref
Hyewon Lim, Hyunmi Son, Gyumin Han & Taehwa Kim. (2024) Stigma and Quality of Life in Lung Cancer Patients: The Mediating Effect of Distress and the Moderated Mediating Effect of Social Support. Asia-Pacific Journal of Oncology Nursing, pages 100483.
Crossref
Crossref
Liping Teng, Zhou Zhou, Yiting Yang, Jun Sun, Yajun Dong, Min Zhu & Teng Wang. (2024) Identifying central symptom clusters and correlates in patients with lung cancer post-chemotherapy: A network analysis. Asia-Pacific Journal of Oncology Nursing 11:4, pages 100383.
Crossref
Crossref
Zhupeng Li, Ting Zhu, Fuqiang Yao, Xiao Shen, Minghao Xu, Linhai Fu, Yuanlin Wu, Jianyi Ding, Jiandong Zhang, Junjun Zhao, Lingjun Dong, Xiang Wang & Guangmao Yu. (2024) LINC00665 promotes glycolysis in lung adenocarcinoma cells via the let-7c-5p/HMMR axis. Journal of Bioenergetics and Biomembranes 56:2, pages 181-191.
Crossref
Crossref
Yu Zhang, Qiuye Jia, Fangfang Li, Xuan Luo, Zhiyuan Wang, Xiaofang Wang, Yanghao Wang, Yinglin Zhang, Muye Li & Li Bian. (2024) Identification of molecular subtypes and a prognostic signature based on m6A/m5C/m1A-related genes in lung adenocarcinoma. Scientific Reports 14:1.
Crossref
Crossref
Yulong Shi, Chongwu Li, Xinben Zhang, Cheng Peng, Peng Sun, Qian Zhang, Leilei Wu, Ying Ding, Dong Xie, Zhijian Xu & Weiliang Zhu. (2024) D3EGFR: a webserver for deep learning-guided drug sensitivity prediction and drug response information retrieval for EGFR mutation-driven lung cancer. Briefings in Bioinformatics 25:3.
Crossref
Crossref
Xu Qian & Qing-He Meng. (2024) Circulating lung cancer biomarkers: From translational research to clinical practice. Tumor Biology 46:s1, pages S27-S33.
Crossref
Crossref
Gustavo Gutiérrez Herrero, Sandra Núñez-Rodríguez, Carla Collazo, Álvaro García-Bustillo, Jerónimo J. González-Bernal, Lucía Castellanos-Romero & Josefa González-Santos. (2024) Retrospective Study of Lung Cancer: Evolution in 16 Years in the Burgos Region. Journal of Clinical Medicine 13:6, pages 1601.
Crossref
Crossref
Ying Zhuo & Yan Song. (2024) Prognostic and immunological implications of paraptosis‐related genes in lung adenocarcinoma: Comprehensive analysis and functional verification of hub gene. Environmental Toxicology.
Crossref
Crossref
Shuyun Wang, Jing Wang, Wenjing Gong, Fang Zhang, Xiaozheng Chen, Huijun Xu, Yali Han, Xuebing Fu, Leirong Wang, Juan Li, Aiqin Gao & Yuping Sun. (2024)
ILT4
facilitates angiogenesis in non‐small cell lung cancer
. Cancer Science.
Crossref
Crossref
Sandip Pravin Patel, Rongrong Wang, Summera Qiheng Zhou, Daniel Sheinson, Ann Johnson & Janet Shin Lee. (2024) Validation of an Updated Algorithm to Identify Patients With Incident Non–Small Cell Lung Cancer in Administrative Claims Databases. JCO Clinical Cancer Informatics:8.
Crossref
Crossref
Scott T Aaronson, Harold A Sackeim, Mei Jiang, Sarah Badejo, Teresa Greco, Mark T Bunker, Charles R Conway, Koen Demyttenaere, Allan H Young, R Hamish McAllister-Williams & A John Rush. (2023) Alternative metrics for characterizing longer-term clinical outcomes in difficult-to-treat depression: II. Sensitivity to treatment effects. Australian & New Zealand Journal of Psychiatry 58:3, pages 250-259.
Crossref
Crossref
Brooks V. Udelsman, Maureen E. Canavan, Peter L. Zhan, Sora Ely, Henry S. Park, Daniel J. Boffa & Vincent J. MaseJrJr. (2024) Overall survival in low-comorbidity patients with stage I non–small cell lung cancer who chose stereotactic body radiotherapy compared to surgery. The Journal of Thoracic and Cardiovascular Surgery 167:3, pages 822-833.e7.
Crossref
Crossref
Jiaqi Liang, Guoshu Bi, Yiwei Huang, Guangyin Zhao, Qihai Sui, Huan Zhang, Yunyi Bian, Jiacheng Yin, Qun Wang, Zhencong Chen & Cheng Zhan. (2024) MAFF confers vulnerability to cisplatin-based and ionizing radiation treatments by modulating ferroptosis and cell cycle progression in lung adenocarcinoma. Drug Resistance Updates 73, pages 101057.
Crossref
Crossref
Aaron C. Tan, Gillianne G. Y. Lai, Stephanie P. L. Saw, Kevin L. M. Chua, Angela Takano, Boon‐Hean Ong, Tina P. T. Koh, Amit Jain, Wan Ling Tan, Quan Sing Ng, Ravindran Kanesvaran, Tanujaa Rajasekaran, Ekaterina Kalashnikova, Derrick Renner, Sumedha Sudhaman, Meenakshi Malhotra, Himanshu Sethi, Minetta C. Liu, Alexey Aleshin, Wan‐Teck Lim, Eng‐Huat Tan, Anders J. Skanderup, Mei‐Kim Ang & Daniel S. W. Tan. (2024) Detection of circulating tumor DNA with ultradeep sequencing of plasma cell‐free DNA for monitoring minimal residual disease and early detection of recurrence in early‐stage lung cancer. Cancer.
Crossref
Crossref
Indranil Sahoo, Jinlei Zhao, Xiaoyan Deng, Myles Gordon Cockburn, Kathy Tossas, Robert Winn & Dipankar Bandyopadhyay. (2024) Lung Cancer Prevalence in Virginia: A Spatial Zipcode-Level Analysis via INLA. Current Oncology 31:3, pages 1129-1144.
Crossref
Crossref
Takuya Kosumi, Masanori Kobayashi, Shigetaka Shimodaira, Haruo Sugiyama & Shigeo Koido. (2024) Dendritic cell vaccination in combination with erlotinib in a patient with inoperable lung adenocarcinoma: a case report. Journal of Medical Case Reports 18:1.
Crossref
Crossref
Nehal J. Lakhani, Drew Rasco, Hengbang Wang, Lichuang Men, Eric Liang, Tommy Fu, Mary C. Collins, Ping Min, Yan Yin, Matthew S. Davids, Dajun Yang & Yifan Zhai. (2024) First-in-Human Study with Preclinical Data of BCL-2/BCL-xL Inhibitor Pelcitoclax in Locally Advanced or Metastatic Solid Tumors. Clinical Cancer Research 30:3, pages 506-521.
Crossref
Crossref
Jordi Remon, Stephanie P.L. Saw, Francesco Cortiula, Pawan Kumar Singh, Jessica Menis, Giannis Mountzios & Lizza E.L. Hendriks. (2024) Perioperative Treatment Strategies in EGFR-Mutant Early-Stage NSCLC: Current Evidence and Future Challenges. Journal of Thoracic Oncology 19:2, pages 199-215.
Crossref
Crossref
Tao Han, Jing Wu, Yafeng Liu, Jiawei Zhou, Rui Miao, Jianqiang Guo, Zhi Xu, Yingru Xing, Ying Bai & Dong Hu. (2024) Integrating bulk-RNA sequencing and single-cell sequencing analyses to characterize adenosine-enriched tumor microenvironment landscape and develop an adenosine-related prognostic signature predicting immunotherapy in lung adenocarcinoma. Functional & Integrative Genomics 24:1.
Crossref
Crossref
Anne Pernille Harlem Dyrbekk, Abdirashid Ali Warsame, Pål Suhrke, Marianne Odnakk Ludahl, Nermin Zecic, Joakim Oliu Moe, Marius Lund-Iversen & Odd Terje Brustugun. (2024) Evaluation of NTRK expression and fusions in a large cohort of early-stage lung cancer. Clinical and Experimental Medicine 24:1.
Crossref
Crossref
Daisy Mehta, Divyani Gupta, Alankar Kafle, Sukhjot Kaur & Tharamani C. Nagaiah. (2023) Advances and Challenges in Nanomaterial-Based Electrochemical Immunosensors for Small Cell Lung Cancer Biomarker Neuron-Specific Enolase. ACS Omega 9:1, pages 33-51.
Crossref
Crossref
Xiaodong Yang, Dongliang Bian, Jie Yang, Liang Duan, Haifeng Wang, Deping Zhao, Gening Jiang, Yuming Zhu & Peng Zhang. (2024) Perioperative immunotherapy for resectable non-small-cell lung cancer. Clinical Cancer Bulletin 3:1.
Crossref
Crossref
Qihai Sui, Zhengyang Hu, Jiaqi Liang, Tao Lu, Yunyi Bian, Xing Jin, Ming Li, Yiwei Huang, Huiqiang Yang, Qun Wang, Zongwu Lin, Zhencong Chen & Cheng Zhan. (2024) Targeting TAM-secreted S100A9 effectively enhances the tumor-suppressive effect of metformin in treating lung adenocarcinoma. Cancer Letters 581, pages 216497.
Crossref
Crossref
Xunxia Zhu, Xiaoyu Chen, Xiaoyong Shen, Yang Liu, Wentao Fu, Bin Wang, Liting Zhao, Fuzhi Yang, Nianping Mo, Gang Zhong, Shuai Jiang & Zhengyao Yang. (2024) PP4R1 accelerates the malignant progression of NSCLC via up-regulating HSPA6 expression and HSPA6-mediated ER stress. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 1871:1, pages 119588.
Crossref
Crossref
Manu S. Goyal, Brian A. Gordon & Susan M. Resnick. 2024. Reference Module in Neuroscience and Biobehavioral Psychology. Reference Module in Neuroscience and Biobehavioral Psychology.
Agata Małgorzata Wilk, Emilia Kozłowska, Damian Borys, Andrea D’Amico, Izabela Gorczewska, Iwona Debosz-Suwińska, Seweryn Gałecki, Krzysztof Fujarewicz, Rafał Suwiński & Andrzej Świerniak. 2024. The Latest Developments and Challenges in Biomedical Engineering. The Latest Developments and Challenges in Biomedical Engineering
163
173
.
Seyed-Hossein Hosseini-Berneti, Mohsen Karami, Fatemeh Bayani, Mehdi Moghaddasi, Ozra Babazade, Pouyan Ebrahimi & Hossein-Ali Nikbakht. (2023) The study of trends in mortality of respiratory system cancers in Babol, North of Iran (2013-2021). Multidisciplinary Respiratory Medicine 18.
Crossref
Crossref
Stefania Volpe, Mattia Zaffaroni, Gaia Piperno, Maria Giulia Vincini, Maria Alessia Zerella, Federico Mastroleo, Federica Cattani, Cristiana Iuliana Fodor, Federica Bellerba, Tiziana Bonaldi, Giuseppina Bonizzi, Francesco Ceci, Marta Cremonesi, Nicola Fusco, Sara Gandini, Cristina Garibaldi, Davide La Torre, Roberta Noberini, Giuseppe Petralia, Lorenzo Spaggiari, Konstantinos Venetis, Roberto Orecchia, Monica Casiraghi & Barbara Alicja Jereczek-Fossa. (2023) Multi-omics integrative modelling for stereotactic body radiotherapy in early-stage non-small cell lung cancer: clinical trial protocol of the MONDRIAN study. BMC Cancer 23:1.
Crossref
Crossref
Martin Carl Tammemägi, Kristin Cina, Andrea K. Borondy Kitts, David Koop, Mark A. Petereit, Michele Sargent & Daniel G. Petereit. (2023) Sensitivity of US Preventive Services Task Force and PLCOm2012 lung cancer screening eligibility criteria in individuals with lung cancer in South Dakota self‐reporting as Indigenous and non‐Indigenous. Cancer 129:24, pages 3894-3904.
Crossref
Crossref
Jenny O’Brien & J. Nicholas Bodor. (2023) Perioperative Immunotherapy in Non-Small Cell Lung Cancer. Current Treatment Options in Oncology 24:12, pages 1790-1801.
Crossref
Crossref
Maria Laura Gritti Paes de Barros, Vinícius G. Silva, Frederico Rafael Moreira, Stela V. Perez, Riad N. Younes & Fernando Conrado Abrão. (2023) Five‐year survival of resectable stage IIIA non‐small cell lung cancer in Brazil. Journal of Surgical Oncology 128:7, pages 1195-1204.
Crossref
Crossref
Kofi Cox, Hassam Ahmed, Priyanshu Saha, Wing Kin Liu, Katharine Aitken, Jason Bernard, Timothy Bishop, Pawan Minhas, Marios Papadopoulos, Francis Johnston, Alicia Piggott, Erlick Pereira, Darren Lui & Mehran Afshar. (2023) Six-Month Survivorship Prediction in Spinal Metastatic Patients by Oncologists Shows Reliable Prognostication. Global Spine Journal.
Crossref
Crossref
Jon Apple, Maral DerSarkissian, Anne Shah, Rose Chang, Yan Chen, Xuanhao He & Justin Chun. (2023) Economic burden of early-stage non-small-cell lung cancer: an assessment of healthcare resource utilization and medical costs. Journal of Comparative Effectiveness Research 12:11.
Crossref
Crossref
Haoran Zhang, Dongming Zhang, Jia Liu, Yuequan Shi, Xiaoyan Liu, Minjiang Chen, Wei Zhong, Jing Zhao, Yan Xu & Mengzhao Wang. (2023)
Clinical significance of
DNA
damage response mutations in stage I and stage
IIIa NSCLC
. Thoracic Cancer 14:32, pages 3191-3201.
Crossref
Crossref
Sareshma Sudhesh Dev, Reyhaneh Farghadani, Syafiq Asnawi Zainal Abidin, Iekhsan Othman & Rakesh Naidu. (2023) Flavonoids as receptor tyrosine kinase inhibitors in lung cancer. Journal of Functional Foods 110, pages 105845.
Crossref
Crossref
Domenic P. J. Germano, Adriana Zanca, Stuart T. Johnston, Jennifer A. Flegg & James M. Osborne. (2023) Free and Interfacial Boundaries in Individual-Based Models of Multicellular Biological systems. Bulletin of Mathematical Biology 85:11.
Crossref
Crossref
Liangyu Zhang, Xun Zhang, Maohao Guan, Fengqiang Yu & Fancai Lai. (2023) In-depth single-cell and bulk-RNA sequencing developed a NETosis-related gene signature affects non-small-cell lung cancer prognosis and tumor microenvironment: results from over 3,000 patients. Frontiers in Oncology 13.
Crossref
Crossref
Zesen Yu, Yu Ji, Jiaji Liu & Ying Wei. (2023) A U-Shaped Convolution Recurrent Network for Spatiotemporal Feature Fusion in 4D-CT Image Registration. A U-Shaped Convolution Recurrent Network for Spatiotemporal Feature Fusion in 4D-CT Image Registration.
Ricardo García-Fumero, Cristina Fernández-López, Miguel Ángel Calleja-Hernández, Manuela Expósito-Ruiz, Jaime Espín & José Expósito-Hernández. (2023) Clinical Outcomes of First-line Therapies for Advanced Non–Small Cell Lung Cancer. American Journal of Clinical Oncology 46:10, pages 433-438.
Crossref
Crossref
Zhengyang Hu, Xing Jin, Weifeng Hong, Qihai Sui, Mengnan Zhao, Yiwei Huang, Ming Li, Qun Wang, Cheng Zhan & Zhencong Chen. (2023) Dissecting the single-cell transcriptome network of macrophage and identifies a signature to predict prognosis in lung adenocarcinoma. Cellular Oncology 46:5, pages 1351-1368.
Crossref
Crossref
Yunlin Jiang, Mingye Zhao, Jiayi Xi, Jiaqi Li, Wenxi Tang & Xueping Zheng. (2023) Cost-effectiveness analysis of atezolizumab in patients with non-small-cell lung cancer ineligible for treatment with a platinum-containing regimen: a United Kingdom health care perspective. Frontiers in Public Health 11.
Crossref
Crossref
Karmen Stanic, Jasna But-Hadzic, Jan Zagar & Martina Vrankar. (2023) Local control and survival after stereotactic body radiation therapy of early-stage lung cancer patients in Slovenia. Radiology and Oncology 57:3, pages 389-396.
Crossref
Crossref
Sive Mullen & Dania Movia. (2023) The role of extracellular vesicles in non-small-cell lung cancer, the unknowns, and how new approach methodologies can support new knowledge generation in the field. European Journal of Pharmaceutical Sciences 188, pages 106516.
Crossref
Crossref
Paison Faida, Mawusse K.I. Attiogbe, Usman Majeed, Jing Zhao, Linlin Qu & Daidi Fan. (2023) Lung cancer treatment potential and limits associated with the STAT family of transcription factors. Cellular Signalling 109, pages 110797.
Crossref
Crossref
Runbin Sun, Fei Fei, Min Wang, Junyi Jiang, Guangyu Yang, Na Yang, Dandan Jin, Zhi Xu, Bei Cao & Juan Li. (2023)
Integration of metabolomics and machine learning revealed tryptophan metabolites are sensitive biomarkers of pemetrexed efficacy in
non‐small
cell lung cancer
. Cancer Medicine 12:18, pages 19245-19259.
Crossref
Crossref
Lin Zhang, Yuan Liu, Jian-Guo Zhuang, Jie Guo, Yan-Tao Li, Yan Dong & Gang Song. (2023) Identification of key genes and biological pathways in lung adenocarcinoma by integrated bioinformatics analysis. World Journal of Clinical Cases 11:23, pages 5504-5518.
Crossref
Crossref
Mahmood Araghi, Reza Mannani, Ali Heidarnejad maleki, Adel Hamidi, Samaneh Rostami, Salar Hozhabri Safa, Fatemeh Faramarzi, Sahar Khorasani, Mina Alimohammadi, Safa Tahmasebi & Reza Akhavan-Sigari. (2023) Recent advances in non-small cell lung cancer targeted therapy; an update review. Cancer Cell International 23:1.
Crossref
Crossref
Yu Fu, Jun Liu, Yan Chen, Zhuo Liu, Hongbo Xia & Haixia Xu. (2023) Gender disparities in lung cancer incidence in the United States during 2001–2019. Scientific Reports 13:1.
Crossref
Crossref
Yuli Wang, Yanbin Pan, Yingbin Luo, Jianchun Wu, Zhihong Fang, Wenjing Teng, Yu Guan & Yan Li. (2023) Elucidation of the anti-lung cancer mechanism of Juan-Liu-San-Jie prescription based on network pharmacology and experimental validation. Heliyon 9:8, pages e18298.
Crossref
Crossref
Dubiao Xian, Yuanyuan Wu, Wenhui Chen, Qingfeng Yan & Yuechang Wu. (2023) Circ_0060937 Contributes to the Development of Lung Cancer via Positively Regulating LAD1 Expression by Binding to miR-1304-5p. Biochemical Genetics 61:4, pages 1433-1450.
Crossref
Crossref
Jonnathan Roldan Ruiz, Marta Fuentes Gago, Luis Chinchilla Tabora, Idalia Gonzalez Morais, José Sayagués, Mar Abad Hernández, Maria Cordovilla Pérez, Maria Ludeña de la Cruz, Edel del Barco Morillo & Marta Rodriguez Gonzalez. (2023) The Impact of Liquid Biopsies Positive for EGFR Mutations on Overall Survival in Non-Small Cell Lung Cancer Patients. Diagnostics 13:14, pages 2347.
Crossref
Crossref
Casey L. Liveringhouse, Kujtim Latifi, Amalin G. Asous, Nghi B. Lam, Stephen A. Rosenberg, Thomas J. Dilling, Gretchen V. MacMillan, Alberto A. Chiappori, Eric B. Haura, Ben Creelan, Jhanelle E. Gray, Tawee Tanvetyanon, Michael R. Shafique, Andreas N. Saltos, Ashley A. Weiner, Jeffrey Clarke, Christopher R. Kelsey, Sungjune Kim, James J. Caudell, Trevor A. Rose, Jose R. Conejo-Garcia, Jiannong Li, Michael J. Schell, Scott J. Antonia & Bradford A. Perez. (2023) Dose-Limiting Pulmonary Toxicity in a Phase 1/2 Study of Radiation and Chemotherapy with Ipilimumab Followed by Nivolumab for Patients With Stage 3 Unresectable Non-Small Cell Lung Cancer. International Journal of Radiation Oncology*Biology*Physics 116:4, pages 837-848.
Crossref
Crossref
Fonthip Chutivanidchayakul, Thitiporn Suwatanapongched & Tananchai Petnak. (2023) Clinical and chest radiographic features of missed lung cancer and their association with patient outcomes. Clinical Imaging 99, pages 73-81.
Crossref
Crossref
Ofer Rotem, Alona Zer, Lilach Yosef, Einat Beery, Hadar Goldvaser, Anna Gutkin, Ron Levin, Elizabeth Dudnik, Tamar Berger, Meora Feinmesser, Adva Levy-Barda, Meir Lahav, Pia Raanani & Orit Uziel. (2023) Blood-Derived Exosomal hTERT mRNA in Patients with Lung Cancer: Characterization and Correlation with Response to Therapy. Biomedicines 11:6, pages 1730.
Crossref
Crossref
Patricia Hogea, Emanuela Tudorache, Ovidiu Fira-Mladinescu, Monica Marc, Diana Manolescu, Felix Bratosin, Ovidiu Rosca, Adelina Mavrea & Cristian Oancea. (2023) The Association of IFN-γ, TNF-α, and Interleukins in Bronchoalveolar Lavage Fluid with Lung Cancer: A Prospective Analysis. Journal of Personalized Medicine 13:6, pages 968.
Crossref
Crossref
Liang Chen, Yiming Weng, Xue Cui, Qian Li, Min Peng & Qibin Song. (2023) Comprehensive analyses of a CD8+ T cell infiltration related gene signature with regard to the prediction of prognosis and immunotherapy response in lung squamous cell carcinoma. BMC Bioinformatics 24:1.
Crossref
Crossref
Elizabeth J. Adams, Joe M. Feinglass, Rachel Hae-Soo Joung & David D. Odell. (2023) Statewide Examination of Access to Cancer Surgery During the COVID-19 Pandemic. Journal of Surgical Research 286, pages 8-15.
Crossref
Crossref
Prashanth Ashok Kumar, Maryam Karimi, Alina Basnet, Lesley Seymour, Robert Kratzke, Elizabeth Brambilla, Thierry Le-Chevalier, Jean-Charles Soria, Ken André Olaussen, Siddhartha Devarakonda, Ramaswamy Govindan, Ming-Sound Tsao, Frances A Shepherd, Stefan Michiels & Stephen Graziano. (2023) Association of Molecular Profiles and Mutational Status With Distinct Histological Lung Adenocarcinoma Subtypes. An Analysis of the LACE-Bio Data. Clinical Lung Cancer.
Crossref
Crossref
Xiaokun Wang, Min Qi, Xu Zhu, Zhengtong Zhao, Yufeng Cao, Daijun Xing, Fuman Wang & Gaoyang Lin. (2023) EZH2 is a biomarker associated with lung cancer diagnosis and immune infiltrates without prognostic specificity: a study based on the cancer genome atlas data*. Oncology and Translational Medicine 9:3, pages 99-114.
Crossref
Crossref
Breanne Freeman, Jessica Mamallapalli, Tengfei Bian, Kayleigh Ballas, Allison Lynch, Alexander Scala, Zhiguang Huo, Kristianna M. Fredenburg, Adriaan W. Bruijnzeel, Carolyn J. Baglole, Junxuan Lu, Ramzi G. Salloum, John Malaty & Chengguo Xing. (2023) Opportunities and Challenges of Kava in Lung Cancer Prevention. International Journal of Molecular Sciences 24:11, pages 9539.
Crossref
Crossref
Anne Pernille Harlem Dyrbekk, Abdirashid Ali Warsame, Pål Suhrke, Marianne Odnakk Ludahl, Joakim Oliu Moe, Inger Johanne Zwicky Eide, Marius Lund-Iversen & Odd Terje Brustugun. (2023) “Evaluation of ROS1 expression and rearrangements in a large cohort of early-stage lung cancer”. Diagnostic Pathology 18:1.
Crossref
Crossref
Isabella Wu & Xin Wang. (2023) A novel approach to topological network analysis for the identification of metrics and signatures in non-small cell lung cancer. Scientific Reports 13:1.
Crossref
Crossref
Valeria Besskaya, Huan Zhang, Yunyi Bian, Jiaqi Liang, Guoshu Bi, Guangyao Shan, Cheng Zhan & Zongwu Lin. (2023)
Hepatic nuclear factor 4 alpha promotes the ferroptosis of lung adenocarcinoma
via
transcriptional activation of cytochrome P450 oxidoreductase
. PeerJ 11, pages e15377.
Crossref
Crossref
Chui-ying Yip, Alastair Greystoke, Seye Abogunrin, Rossella Belleli, Danilo Di Maio, Peter Rouse & Nick Jovanoski. (2023) Cost-effectiveness analysis of adjuvant atezolizumab in stage II-IIIA non-small cell lung cancer expressing ≥50% PD-L1: A United Kingdom health care perspective. Lung Cancer 179, pages 107171.
Crossref
Crossref
Giulia Pasello, Daniela Scattolin, Laura Bonanno, Francesca Caumo, Andrea Dell'Amore, Elena Scagliori, Mariaenrica Tinè, Fiorella Calabrese, Gaetano Benati, Matteo Sepulcri, Cristina Baiocchi, Michele Milella, Federico Rea & Valentina Guarneri. (2023) Secondary prevention and treatment innovation of early stage non-small cell lung cancer: Impact on diagnostic-therapeutic pathway from a multidisciplinary perspective. Cancer Treatment Reviews 116, pages 102544.
Crossref
Crossref
Margaret Wallen, Farrukh Aqil, Wendy Spencer & Ramesh C. Gupta. (2023) Milk/colostrum exosomes: A nanoplatform advancing delivery of cancer therapeutics. Cancer Letters 561, pages 216141.
Crossref
Crossref
Laurelle van Tilburg, Steffi E. M. van de Ven, Manon C. W. Spaander, Laurens A. van Kleef, Robin Cornelissen, Marco J. Bruno & Arjun D. Koch. (2022) Prevalence of lung tumors in patients with esophageal squamous cell carcinoma and vice versa: a systematic review and meta-analysis. Journal of Cancer Research and Clinical Oncology 149:5, pages 1811-1823.
Crossref
Crossref
Mahdi Sheikh, Shama Virani, Hilary A. Robbins, Lenka Foretova, Ivana Holcatova, Vladimir Janout, Jolanta Lissowska, Marie Navratilova, Anush Mukeriya, Miodrag Ognjanovic, Beata Swiatkowska, David Zaridze & Paul Brennan. (2023) Survival and prognostic factors of early‐stage non‐small cell lung cancer in Central and Eastern Europe: A prospective cohort study. Cancer Medicine 12:9, pages 10563-10574.
Crossref
Crossref
Xueyan Liang, Xiaoyu Chen, Huijuan Li & Yan Li. (2023) Cost-effectiveness of cemiplimab plus chemotherapy versus chemotherapy for the treatment of advanced non-small cell lung cancer. Frontiers in Oncology 13.
Crossref
Crossref
Junhao Zhang & Hong Zhang. (2023) A Bayesian neural network model based on CT images for staging non-small cell lung cancer. A Bayesian neural network model based on CT images for staging non-small cell lung cancer.
Kangjoon Kim, Jibeom Lee, Jeong-Yun Lee, Seung Hyun Yong, Eun Young Kim, Ji Ye Jung, Young Ae Kang, Moo Suk Park, Young Sam Kim, Chang-Myung Oh & Sang Hoon Lee. (2023) Clinical features and molecular genetics associated with brain metastasis in suspected early-stage non-small cell lung cancer. Frontiers in Oncology 13.
Crossref
Crossref
Kui Fan, Bo-hui Zhang, Deng Han & Yun-chuan Sun. (2023) EZH2 as a prognostic-related biomarker in lung adenocarcinoma correlating with cell cycle and immune infiltrates. BMC Bioinformatics 24:1.
Crossref
Crossref
Mohamed Said Ismail, Loay Kassem, Ahmed Al-Husseiny Ali, Fatma Elzahraa Ahmed, Mohamed Shalaby & Sally Magdy. (2023) Molecular patterns of egyptian patients with non-squamous non-small-cell lung cancers: a clinicopathological study. Journal of the Egyptian National Cancer Institute 35:1.
Crossref
Crossref
Jay M. Lee, Rongrong Wang, Ann Johnson, Sarika Ogale, Matthew Kent & Janet S. Lee. (2023) Economic Burden of Recurrence Among Resected Medicare Patients With Early Stage NSCLC. JTO Clinical and Research Reports 4:4, pages 100487.
Crossref
Crossref
Xiaodi Ju, Jiayuan Bai, Yiwei She, Rong Zheng, Xiuzhi Xu, Wenru Wang & Jingfang Hong. (2023) Symptom cluster trajectories and sentinel symptoms during the first cycle of chemotherapy in patients with lung cancer. European Journal of Oncology Nursing 63, pages 102282.
Crossref
Crossref
Bregje M. Koomen, Mirthe de Boer, Carmen van Dooijeweert, Anne S. R. van Lindert, Ivette A. G. Deckers, Quirinus J. M. Voorham & Stefan M. Willems. (2022) Nationwide differences in cytology fixation and processing methods and their impact on interlaboratory variation in PD-L1 positivity. Virchows Archiv 482:4, pages 707-720.
Crossref
Crossref
Jiaqi Liang, Guangyin Zhao, Yunyi Bian, Guoshu Bi, Qihai Sui, Huan Zhang, Haochun Shi, Guangyao Shan, Yiwei Huang, Zhencong Chen, Lin Wang & Cheng Zhan. (2023) HNF4G increases cisplatin resistance in lung adenocarcinoma via the MAPK6/Akt pathway. PeerJ 11, pages e14996.
Crossref
Crossref
Hiba Hammad Altaq, Miloni Parmar, Talal Syed Hussain, Daouk J. Salim & Fawad A. Chaudry. (2023) The Use of Robotic-Assisted Bronchoscopy in the Diagnostic Evaluation of Peripheral Pulmonary Lesions: A Paradigm Shift. Diagnostics 13:6, pages 1049.
Crossref
Crossref
Iktej Singh Jabbal, Saad Sabbagh, Mira Itani, Barbara Dominguez, Mohamed Mohanna, Valencia Henry, Hong Liang, Diana Saravia, Tiffany George, Zeina Nahleh, Evan Alley & Rafael Arteta-Bulos. (2023) Factors Associated with the Decision to Decline Chemotherapy in Metastatic Non-Small Cell Lung Cancer. Cancers 15:6, pages 1686.
Crossref
Crossref
Suyash M. Patil, Druva Sarika Barji, Sophia Aziz, David A. McChesney, Shapali Bagde, Pavan Muttil & Nitesh K. Kunda. (2023) Pulmonary delivery of spray-dried Nisin ZP antimicrobial peptide for non-small cell lung cancer (NSCLC) treatment. International Journal of Pharmaceutics 634, pages 122641.
Crossref
Crossref
Weiqian Hou, Liwen Zhai, Yujie Yang, Shanshan Gu, Conghui Li, Yao Yang & Yi Zhu. (2023) Is physical activity effective against cancer-related fatigue in lung cancer patients? An umbrella review of systematic reviews and meta-analyses. Supportive Care in Cancer 31:3.
Crossref
Crossref
Rishika Sharma, Sarika Ogale, Nathaniel J. Smith & Janet Shin Lee. (2022) Estimating recurrences prevented and costs avoided with atezolizumab in early non‐small cell lung cancer in the United States. Cancer Medicine 12:6, pages 7450-7458.
Crossref
Crossref
Terenzio Cosio, Filadelfo Coniglione, Valeria Flaminio, Roberta Gaziano, Deborah Coletta, Rosalba Petruccelli, Emi Dika, Luca Bianchi & Elena Campione. (2023) Pyodermitis during Nivolumab Treatment for Non-Small Cell Lung Cancer: A Case Report and Review of the Literature. International Journal of Molecular Sciences 24:5, pages 4580.
Crossref
Crossref
Mariaenrica Tinè, Davide Biondini, Marco Damin, Umberto Semenzato, Erica Bazzan & Graziella Turato. (2023) Extracellular Vesicles in Lung Cancer: Bystanders or Main Characters?. Biology 12:2, pages 246.
Crossref
Crossref
Mohammadreza Lashkarizadeh, Mahdiyeh Lashkarizadeh, Meead Nikian & Maryam Kouhestani Parizi. (2023) The expression of HER2/neu in patients with lung cancer and its associated factors. The Clinical Respiratory Journal 17:2, pages 90-95.
Crossref
Crossref
Vladimir Jurisic, Jasmina Obradovic, Nadja Nikolic, Jovan Javorac, Branislav Perin & Jelena Milasin. (2022) Analyses of P16INK4a gene promoter methylation relative to molecular, demographic and clinical parameters characteristics in non-small cell lung cancer patients: A pilot study. Molecular Biology Reports 50:2, pages 971-979.
Crossref
Crossref
Yanan Wu, Meng Yuan, Chenlin Wang, Yanfei Chen, Yan Zhang & Jiandong Zhang. (2023) T lymphocyte cell: A pivotal player in lung cancer. Frontiers in Immunology 14.
Crossref
Crossref
Wen-Fang Tang, Hong-Yu Ye, Xuan Tang, Jian-Wei Su, Kang-Mei Xu, Wen-Zhao Zhong & Yi Liang. (2023) Adjuvant immunotherapy in early-stage resectable non–small cell lung cancer: A new milestone. Frontiers in Oncology 13.
Crossref
Crossref
Yan Ding, Ruilin Hou, Jianqiang Yu, Chengguo Xing, Chunlin Zhuang & Zhuo Qu. (2023) Dietary Phytochemicals as Potential Chemopreventive Agents against Tobacco-Induced Lung Carcinogenesis. Nutrients 15:3, pages 491.
Crossref
Crossref
Xiao-Han Shen, Yung-Yueh Chang, Rong-Qi Pham, Wei-An Chen, Fang-Yu Li, Wan-Chin Huang & Yu-Wen Lin. (2023) Secular-Trend Analysis of the Incidence Rate of Lung Squamous Cell Carcinoma in Taiwan. International Journal of Environmental Research and Public Health 20:2, pages 1614.
Crossref
Crossref
Onsurang Wattanathamsan, Naphat Chantaravisoot, Piriya Wongkongkathep, Sakkarin Kungsukool, Paninee Chetprayoon, Pithi Chanvorachote, Chanida Vinayanuwattikun & Varisa Pongrakhananon. (2023) Inhibition of histone deacetylase 6 destabilizes ERK phosphorylation and suppresses cancer proliferation via modulation of the tubulin acetylation-GRP78 interaction. Journal of Biomedical Science 30:1.
Crossref
Crossref
Dalia Ahmed Elmaghraby, Ahmed Ali Alshalla, Anas Alyahyan, Muntathir Altaweel, Ahmad Mohammed Al ben Hamad, Khalid Mohammed Alhunfoosh, Mohammed F. AlJuwaysim, Duaa Jawad Aljumah & Mohammed Abdullah Albahrani. (2023) Public Knowledge, Practice, and Attitude Regarding Cancer Screening: A Community-Based Study in Saudi Arabia. International Journal of Environmental Research and Public Health 20:2, pages 1114.
Crossref
Crossref
Zhang Linwan, Kazuya Kondo, Takae Bando, Naoya Kawakita, Hiroaki Toba, Yoshie Imai & Hiromitsu Takizawa. (2023) Assessment of dyspnea, ADL, and QOL in the perioperative period in lung cancer patients treated with minimally invasive surgery. The Journal of Medical Investigation 70:3.4, pages 388-402.
Crossref
Crossref
Jietao Lin, Lingling Sun, Hanrui Chen, Wenmin Chen, Zexin Zhang, Yang Cao & Lizhu Lin. (2023) Chinese and Western Integrative Medicine for Stage IIIb-IVb Non-Small Cell Lung Cancer: Design and Rationale of a Multi-center, Prospective Registry (NSCLC-Chinese and Western Integrative Medicine cohort). Integrative Cancer Therapies 22.
Crossref
Crossref
Pang-Shuo Perng, Hui-Ping Hsu, Po-Hsuan Lee, Chi-Chen Huang, Chien-Chung Lin & Jung-Shun Lee. (2023) Correlation of EGFR mutation subtypes and survival in surgically treated brain metastasis from non-small-cell lung cancer. Asian Journal of Surgery 46:1, pages 269-276.
Crossref
Crossref
Kun Luo, Shufeng Xu, Jing Zhao & Feifei Liu. (2022) Upregulation of lncRNA PINK1-AS Predicts the Distant Metastasis of Patients with Small Cell Lung Cancer. Molecular Biotechnology 65:1, pages 28-33.
Crossref
Crossref
William E. Rallya, Christopher Russo & John Hodgson. 2023. Anesthesia for Oncological Surgery. Anesthesia for Oncological Surgery
215
219
.
Katarzyna Wadowska, Piotr Błasiak, Adam Rzechonek, Iwona Bil-Lula & Mariola Śliwińska-Mossoń. (2022) Hepcidin as a Diagnostic Biomarker in Anaemic Lung Cancer Patients. Cancers 15:1, pages 224.
Crossref
Crossref
Seung Yeob Hyun, Hye-Young Min, Ho Jin Lee, Jaebeom Cho, Hye-Jin Boo, Myungkyung Noh, Hyun-Ji Jang, Hyo-Jong Lee, Choon-Sik Park, Jong-Sook Park, Young Kee Shin & Ho-Young Lee. (2022) Ninjurin1 drives lung tumor formation and progression by potentiating Wnt/β-Catenin signaling through Frizzled2-LRP6 assembly. Journal of Experimental & Clinical Cancer Research 41:1.
Crossref
Crossref
Panagiotis Paliogiannis, Maria Colombino, Maria Cristina Sini, Antonella Manca, Milena Casula, Grazia Palomba, Marina Pisano, Valentina Doneddu, Angelo Zinellu, Davide Santeufemia, Pietro Pirina, Alessandro Giuseppe Fois, Carlo Putzu, Giorgio Astara, Mario Scartozzi, Anna Maria Carta, Giuseppe Porcu, Gianfranco Bardino, Claudio Sini, Francesca Capelli, Maria Giuseppina Sarobba, Giovanni Sotgiu, Antonio Cossu & Giuseppe Palmieri. (2022) Global prognostic impact of driver genetic alterations in patients with lung adenocarcinoma: a real-life study. BMC Pulmonary Medicine 22:1.
Crossref
Crossref
Naghib Bogere, Felix Bongomin, Andrew Katende, Blair Andrew Omaido, Elizabeth Namukwaya, Harriet Mayanja-Kizza & Victoria Walusansa. (2022) A 10-year retrospective study of lung cancer in Uganda. BMC Cancer 22:1.
Crossref
Crossref
Andrew F. Nyein, Shahla Bari, Stephanie Hogue, Yayi Zhao, Bradley Maller, Sybil Sha, Maria F. Gomez, Dana E. Rollison & Lary A. Robinson. (2022) Effect of prior antibiotic or chemotherapy treatment on immunotherapy response in non-small cell lung cancer. BMC Cancer 22:1.
Crossref
Crossref
Hirotsugu Kenmotsu, Shunichi Sugawara, Yasutaka Watanabe, Haruhiro Saito, Morihito Okada, Toyofumi Fengshi Chen‐Yoshikawa, Yuichiro Ohe, Wataru Nishio, Shizuka Nakagawa & Haruka Nagao. (2022)
Adjuvant atezolizumab in Japanese patients with resected stage
IB‐IIIA
non‐small cell lung cancer (
IMpower010
)
. Cancer Science 113:12, pages 4327-4338.
Crossref
Crossref
Bilal Tarabay, Antoine Gennari, Van Tri Truong, Jesse Shen, Rama Dib, Nicholas Newmann, Fidaa Al-Shakfa, Sung Joo Yuh, Daniel Shedid, Ghassan Boubez & Zhi Wang. (2022) Which Scoring System Is the Most Accurate for Assessing Survival Prognosis in Patients Undergoing Surgery for Spinal Metastases from Lung Cancer? A Single-Center Experience. World Neurosurgery 168, pages e408-e417.
Crossref
Crossref
Anil Vachani, Nikki M. Carroll, Michael J. Simoff, Christine Neslund-Dudas, Stacey Honda, Robert T. Greenlee, Katharine A. Rendle, Andrea Burnett-Hartman & Debra P. Ritzwoller. (2022) Stage Migration and Lung Cancer Incidence After Initiation of Low-Dose Computed Tomography Screening. Journal of Thoracic Oncology 17:12, pages 1355-1364.
Crossref
Crossref
Kaiyong Zou, Peiyuan Sun, Huang Huang, Haoran Zhuo, Ranran Qie, Yuting Xie, Jiajun Luo, Ni Li, Jiang Li, Jie He, Briseis Aschebrook-Kilfoy & Yawei Zhang. (2022) Etiology of lung cancer: Evidence from epidemiologic studies. Journal of the National Cancer Center 2:4, pages 216-225.
Crossref
Crossref
Hebatallah M. Saad, Ghada F. Tourky, Hayder M. Al-kuraishy, Ali I. Al-Gareeb, Ahmed M. Khattab, Sohaila A. Elmasry, Abdulrahman A. Alsayegh, Zaki H. Hakami, Ahmad Alsulimani, Jean-Marc Sabatier, Marwa W. Eid, Hazem M. Shaheen, Ali A. Mohammed, Gaber El-Saber Batiha & Michel De Waard. (2022) The Potential Role of MUC16 (CA125) Biomarker in Lung Cancer: A Magic Biomarker but with Adversity. Diagnostics 12:12, pages 2985.
Crossref
Crossref
D. Behera. (2022) Lung Cancer in India–Part I. The Indian Journal of Chest Diseases and Allied Sciences 63:3, pages 143-192.
Crossref
Crossref
Belle H. de Rooij, Corina van den Hurk, Veerle Smaardijk, Paz Fernandez-Ortega, Arturo Navarro-Martin, Lidia Barberio, Matthias Guckenberger, Severin Schmid, Iris Walraven, Susan Vallow, Christina Kotsi, Matthias Preusser, Erika Mosor, Jente M. Klok, Annemarie Becker, Alessandra Milani, Lyudmil Ninov & Lonneke V. van de Poll-Franse. (2022) Development of an updated, standardized, patient-centered outcome set for lung cancer. Lung Cancer 173, pages 5-13.
Crossref
Crossref
Suyash M. Patil & Nitesh K. Kunda. (2022) Nisin ZP, an Antimicrobial Peptide, Induces Cell Death and Inhibits Non-Small Cell Lung Cancer (NSCLC) Progression in vitro in 2D and 3D Cell Culture. Pharmaceutical Research 39:11, pages 2859-2870.
Crossref
Crossref
Lianyue Qu, Yulong Tian, Fan Wang & Zixuan Li. (2022) NOVA1 promotes NSCLC proliferation and invasion by activating Wnt/β-catenin signaling. BMC Cancer 22:1.
Crossref
Crossref
Xinmin Zhao, Xianghua Wu, Hui Yu, Huijie Wang, Si Sun, Zhihuang Hu, Cuicui Liu, Junli Zhang, Yang Shao & Jialei Wang. (2022) Prognostic value of hematologic parameters in advanced non-small cell lung cancer patients receiving anti-PD-1 inhibitors. Frontiers in Immunology 13.
Crossref
Crossref
Huijun Cao, Zhiqiang Wang, Ying Wang, Lijuan Ye, Ruilei Li, Yuanbo Xue, Ke Li, Tiannan Di, Tao Li, Zonglin Fan, Yanyan Liu, Jiyin Guo, Hong Yao & Chunlei Ge. (2022) PPP1R14D promotes the proliferation, migration and invasion of lung adenocarcinoma via the PKCα/BRAF/MEK/ERK signaling pathway. International Journal of Oncology 61:6.
Crossref
Crossref
Wen-Ru Chou, Ben-Chang Shia, Yen-Chun Huang, Chieh-Wen Ho & Mingchih Chen. (2022) Survival Analysis in Patients with Lung Cancer and Subsequent Primary Cancer: A Nationwide Cancer Registry Study. Journal of Clinical Medicine 11:19, pages 5944.
Crossref
Crossref
Xueli Tian, Rui Wang, Tingxuan Gu, Fayang Ma, Kyle Vaughn Laster, Xiang Li, Kangdong Liu, Mee-Hyun Lee & Zigang Dong. (2022) Costunolide is a dual inhibitor of MEK1 and AKT1/2 that overcomes osimertinib resistance in lung cancer. Molecular Cancer 21:1.
Crossref
Crossref
Eva-Maria Talvitie, Lassi Liljeroos, Heikki Vilhonen, Katri Orte, Ilmo Leivo, Markku Kallajoki & Pekka Taimen. (2022) Comprehensive genomic profiling of Finnish lung adenocarcinoma cohort reveals high clinical actionability and SMARCA4 altered tumors with variable histology and poor prognosis. Neoplasia 32, pages 100832.
Crossref
Crossref
Mengqian Zhang, Xiaoning He, Jing Wu, Xinyue Wang, Qian Jiang & Feng Xie. (2022) How Do Treatment Preferences of Patients With Cancer Compare With Those of Oncologists and Family Members? Evidence From a Discrete Choice Experiment in China. Value in Health 25:10, pages 1768-1777.
Crossref
Crossref
Suyash M. Patil & Nitesh K. Kunda. (2022) Anticancer activity of D-LAK-120A, an antimicrobial peptide, in non-small cell lung cancer (NSCLC). Biochimie 201, pages 7-17.
Crossref
Crossref
Jingjing Tang, Kangkang Gu, Jing Mi, Wenhao Zhang, Yunhao Fang, Yuwei Li & Beichen Wang. (2022) Spatio-temporal Distribution Characteristics and Environmental Impact Factors of Lung Cancer Mortality: A Case Study of Yuhui District in Bengbu City, China. Chinese Geographical Science 32:5, pages 867-882.
Crossref
Crossref
Paulina Olszewska, Barbara Pazdrak & Marian L. Kruzel. (2022) Human Lactoferrin Synergizes with Etoposide to Inhibit Lung Adenocarcinoma Cell Growth While Attenuating Etoposide-Mediated Cytotoxicity of Human Endothelial Cells. Biomedicines 10:10, pages 2429.
Crossref
Crossref
Yan Li, Xueyan Liang, Tong Yang, Sitong Guo & Xiaoyu Chen. (2022) Pembrolizumab vs cemiplimab for the treatment of advanced non-small cell lung cancer with PD-L1 expression levels of at least 50%: A network meta-analysis and cost-effectiveness analysis. Frontiers in Oncology 12.
Crossref
Crossref
Yifan Wang, Jingguo Hu, Yu Sun, Bo Song, Yan Zhang, Yusong Lu & Haitao Ma. (2022) Metformin Synergizes with PD-L1 Monoclonal Antibody Enhancing Tumor Immune Response in Treating Non-Small Cell Lung Cancer and Its Molecular Mechanism Investigation. Evidence-Based Complementary and Alternative Medicine 2022, pages 1-9.
Crossref
Crossref
Qun Zhang, Yuan Dai, Hongda Liu, Wenkui Sun, Yuming Huang, Zheng Gong, Shanlin Dai, Hui Kong & Weiping Xie. (2022) Causes of death and conditional survival estimates of long-term lung cancer survivors. Frontiers in Immunology 13.
Crossref
Crossref
Xiaodong Yang, Zhao An, Zhengyang Hu, Junjie Xi, Chenyang Dai & Yuming Zhu. (2022) Expression Analysis of Ligand-Receptor Pairs Identifies Cell-to-Cell Crosstalk between Macrophages and Tumor Cells in Lung Adenocarcinoma. Journal of Immunology Research 2022, pages 1-15.
Crossref
Crossref
Guohua Jia, Shuimei Zhou, Tangpeng Xu, Yabing Huang & Xiangpan Li. (2022) Conversion therapy from unresectable stage IIIC non-small-cell lung cancer to radical surgery via anti-PD-1 immunotherapy combined with chemotherapy and anti-angiogenesis: A case report and literature review. Frontiers in Oncology 12.
Crossref
Crossref
A. A. Fedorov, N. A. Ermak, T. S. Gerashchenko, E. B. Topolnitskii, N. A. Shefer, E. O. Rodionov & M. N. Stakheyeva. (2022) Polarization of macrophages: mechanisms, markers and factors of induction. Siberian journal of oncology 21:4, pages 124-136.
Crossref
Crossref
Darryl Somayaji, Young S. Seo, Gregory E. Wilding & Ekaterina Noyes. (2022) A Multilevel Approach to Investigate Relationships Between Healthcare Resources and Lung Cancer. Nursing Research 71:5, pages 360-369.
Crossref
Crossref
Dahiana Amarillo, Andreina Brugnini, Natalia Trías, Virginia Rodriguez Sande, Siul Salisbury, Mauricio Cuello & Daniela Lens. (2022) Circulating T regulatory cell subsets in patients with untreated lung cancer. Clinical and Translational Oncology 24:9, pages 1755-1763.
Crossref
Crossref
Jun Shao, Jingwei Li, Lujia Song, Qiuyao He, Yuxuan Wu, Linhui Li, Dan Liu, Chengdi Wang & Weimin Li. (2021)
The number of brain metastases predicts the survival of non‐small cell lung cancer patients with
EGFR
mutation status
. Cancer Reports 5:9.
Crossref
Crossref
David J. Benjamin, Alyson Haslam, Jenny Gill & Vinay Prasad. (2022) Targeted therapy in lung cancer: Are we closing the gap in years of life lost?. Cancer Medicine 11:18, pages 3417-3424.
Crossref
Crossref
Florence Chaudot, Pascal Sève, Antoine Rousseau, Alexandre Thibault Jacques Maria, Pierre Fournie, Pierre Lozach, Jeremy Keraen, Marion Servant, Romain Muller, Baptiste Gramont, Sara Touhami, Habeeb Mahmoud, Pierre-Antoine Quintart, Stéphane Dalle, Olivier Lambotte, Laurent Kodjikian & Yvan Jamilloux. (2022) Ocular Inflammation Induced by Immune Checkpoint Inhibitors. Journal of Clinical Medicine 11:17, pages 4993.
Crossref
Crossref
Asma M Aman, Luis M García-Marín, Jackson G Thorp, Adrian I Campos, Gabriel Cuellar-Partida, Nicholas G Martin & Miguel E Rentería. (2022) Phenome-wide screening of the putative causal determinants of depression using genetic data. Human Molecular Genetics 31:17, pages 2887-2898.
Crossref
Crossref
Nicholas W. Bucknell, José Belderbos, David A. Palma, Puneeth Iyengar, Pamela Samson, Kevin Chua, Daniel Gomez, Fiona McDonald, Alexander V. Louie, Corinne Faivre-Finn, Gerard G. Hanna & Shankar Siva. (2022) Avoiding Toxicity With Lung Radiation Therapy: An IASLC Perspective. Journal of Thoracic Oncology 17:8, pages 961-973.
Crossref
Crossref
Zhaojun Wan, Kai Wang, Xiangfu Yin, Xiangting Guo, Guoli Cheng & Jihong Pan. (2022) Renal Abscess Caused by Crizotinib: A Rare Case Report. Frontiers in Oncology 12.
Crossref
Crossref
Xiaodong Zhu, Yi Xu & Zhongbiao Deng. (2022) miR-320 Overexpression Affects Lung Cancer Macrophage M2 Polarization Through Targeting Vascular Endothelial Growth Factor A (VEGFA). Journal of Biomaterials and Tissue Engineering 12:7, pages 1460-1465.
Crossref
Crossref
Cui Yu-Rong, Sun Fang-Bin, Yin Meng-Fan, Fu Jia-Ning, Bu Wei-Xiao, Mu Hua-Xia & Kong Yu-Jia. (2022) Prognostic analysis of patients with non-small cell lung cancer based on Bayesian network model. Prognostic analysis of patients with non-small cell lung cancer based on Bayesian network model.
Haiming Luo, Changwen Yang, Dong Kuang, Sixiang Shi & Annie W. Chan. (2022) Visualizing dynamic changes in PD-L1 expression in non-small cell lung carcinoma with radiolabeled recombinant human PD-1. European Journal of Nuclear Medicine and Molecular Imaging 49:8, pages 2735-2745.
Crossref
Crossref
Hongyong Leng, Cheng Chen, Rumeng Si, Chen Chen, Hanwen Qu & Xiaoyi Lv. (2022) Accurate screening of early‐stage lung cancer based on improved ResNeXt model combined with serum Raman spectroscopy. Journal of Raman Spectroscopy 53:7, pages 1302-1311.
Crossref
Crossref
Marina Domingo-Vidal, Diana Whitaker-Menezes, Mehri Mollaee, Zhao Lin, Madalina Tuluc, Nancy Philp, Jennifer M. Johnson, Tingting Zhan, Joseph Curry & Ubaldo Martinez-Outschoorn. (2022) Monocarboxylate Transporter 4 in Cancer-Associated Fibroblasts Is a Driver of Aggressiveness in Aerodigestive Tract Cancers. Frontiers in Oncology 12.
Crossref
Crossref
Karma M. Fathalla, Sherin M. Youssef & Nourhan Mohammed. (2022) DETECT-LC: A 3D Deep Learning and Textural Radiomics Computational Model for Lung Cancer Staging and Tumor Phenotyping Based on Computed Tomography Volumes. Applied Sciences 12:13, pages 6318.
Crossref
Crossref
Hanne Mariën, Elien Derveaux, Karolien Vanhove, Peter Adriaensens, Michiel Thomeer & Liesbet Mesotten. (2022) Changes in Metabolism as a Diagnostic Tool for Lung Cancer: Systematic Review. Metabolites 12:6, pages 545.
Crossref
Crossref
Chuan-Tsung Su & Jih-Huah Wu. (2022) Management of Combined Therapy (Ceritinib, A. cinnamomea, G. lucidum, and Photobiomodulation) in Advanced Non-Small-Cell Lung Cancer: A Case Report. Life 12:6, pages 862.
Crossref
Crossref
Ruiwen Ding, Prateek Prasanna, Germán Corredor, Cristian Barrera, Philipp Zens, Cheng Lu, Priya Velu, Patrick Leo, Niha Beig, Haojia Li, Paula Toro, Sabina Berezowska, Vipul Baxi, David Balli, Merzu Belete, David L. Rimm, Vamsidhar Velcheti, Kurt Schalper & Anant Madabhushi. (2022) Image analysis reveals molecularly distinct patterns of TILs in NSCLC associated with treatment outcome. npj Precision Oncology 6:1.
Crossref
Crossref
Prameela Kandra, Rajender Nandigama, Bastian Eul, Magdalena Huber, Sebastian Kobold, Werner Seeger, Friedrich Grimminger & Rajkumar Savai. (2022) Utility and Drawbacks of Chimeric Antigen Receptor T Cell (CAR-T) Therapy in Lung Cancer. Frontiers in Immunology 13.
Crossref
Crossref
Arun Chockalingam, Menelaos Konstantinidis, Brandon Koo, John Timothy Moon, Andrew Tran, Sahar Nourouzpour, Emily Lawson, Kathleen Fox, Peiman Habibollahi, Bruno Odisio, Mohammed Loya, Ali Bassir & Nariman Nezami. (2022) Surgical resection, radiotherapy and percutaneous thermal ablation for treatment of stage 1 non-small cell lung cancer: protocol for a systematic review and network meta-analysis. BMJ Open 12:6, pages e057638.
Crossref
Crossref
Guen Tae Kim, Eun Young Kim, Su-Hyun Shin, Hyowon Lee, Se Hee Lee, Kaapjoo Park, Ki-Young Sohn, Sun Young Yoon & Jae Wha Kim. (2022) PLAG alleviates cisplatin-induced cachexia in lung cancer implanted mice. Translational Oncology 20, pages 101398.
Crossref
Crossref
Nan Wei, Qian Li, Shaopeng Chen, Shengmin Xu & Lijun Wu. (2022) Enhanced radiosensitivity by 6-thio-dG via increasing telomere dysfunction and ataxia telangiectasia mutated inhibition in non-small cell lung cancer. Radiation Medicine and Protection 3:2, pages 64-71.
Crossref
Crossref
Guoshu Bi, Jiaqi Liang, Mengnan Zhao, Huan Zhang, Xing Jin, Tao Lu, Yuansheng Zheng, Yunyi Bian, Zhencong Chen, Yiwei Huang, Valeria Besskaya, Cheng Zhan, Qun Wang & Lijie Tan. (2022) miR-6077 promotes cisplatin/pemetrexed resistance in lung adenocarcinoma via CDKN1A/cell cycle arrest and KEAP1/ferroptosis pathways. Molecular Therapy - Nucleic Acids 28, pages 366-386.
Crossref
Crossref
Janani Reisenauer, Jennifer D. Duke, Ryan Kern, Sebastian Fernandez-Bussy & Eric Edell. (2022) Combining Shape-Sensing Robotic Bronchoscopy With Mobile Three-Dimensional Imaging to Verify Tool-in-Lesion and Overcome Divergence: A Pilot Study. Mayo Clinic Proceedings: Innovations, Quality & Outcomes 6:3, pages 177-185.
Crossref
Crossref
Bahar Zehra Camurdanoglu Weber, Samet Agca, Aylin Domaniku, Sevval Nur Bilgic, Dilsad H. Arabaci & Serkan Kir. (2022) Inhibition of epidermal growth factor receptor suppresses parathyroid hormone‐related protein expression in tumours and ameliorates cancer‐associated cachexia. Journal of Cachexia, Sarcopenia and Muscle 13:3, pages 1582-1594.
Crossref
Crossref
Jiaqi Liang, Zhencong Chen, Yiwei Huang, Guoshu Bi, Yunyi Bian, Xing Jin, Huan Zhang, Qihai Sui, Cheng Zhan & Qun Wang. (2022) Signatures of malignant cells and novel therapeutic targets revealed by single‐cell sequencing in lung adenocarcinoma. Cancer Medicine 11:11, pages 2244-2258.
Crossref
Crossref
Jiangbo Li, Zhijia Sun, Yingshu Cui, Lingmei Qin, Fengyun Wu, Yufang Li, Nan Du & Xiaosong Li. (2022) Knockdown of LMNB1 Inhibits the Proliferation of Lung Adenocarcinoma Cells by Inducing DNA Damage and Cell Senescence. Frontiers in Oncology 12.
Crossref
Crossref
Li-Na Wang, Zi-Teng Zhang, Li Wang, Hai-Xiang Wei, Tao Zhang, Li-Ming Zhang, Hang Lin, Heng Zhang & Shao-Qiang Wang. (2022) TGF-β1/SH2B3 axis regulates anoikis resistance and EMT of lung cancer cells by modulating JAK2/STAT3 and SHP2/Grb2 signaling pathways. Cell Death & Disease 13:5.
Crossref
Crossref
Zu-Chian Chiang, Shubin Fang, Yang-kun Shen, Dongya Cui, Huanjiao Weng, Dawei Wang, Yuxiang Zhao, Jizhen Lin & Qi Chen. (2022) Development of Novel CD47-Specific ADCs Possessing High Potency Against Non-Small Cell Lung Cancer in vitro and in vivo. Frontiers in Oncology 12.
Crossref
Crossref
Maximilian Achim Pfeffer & Sai Ho Ling. (2022) Evolving Optimised Convolutional Neural Networks for Lung Cancer Classification. Signals 3:2, pages 284-295.
Crossref
Crossref
Michael Koller, Jammbe Z. Musoro, Krzysztof Tomaszewski, Corneel Coens, Madeleine T. King, Mirjam A.G. Sprangers, Mogens Groenvold, Kim Cocks, Galina Velikova, Hans-Henning Flechtner & Andrew Bottomley. (2022) Minimally important differences of EORTC QLQ-C30 scales in patients with lung cancer or malignant pleural mesothelioma – Interpretation guidance derived from two randomized EORTC trials. Lung Cancer 167, pages 65-72.
Crossref
Crossref
William A. Stokes, Niya Xiong, Yuan Liu, Kristin A. Higgins, Sibo Tian, Jeffrey D. Bradley, Drew Moghanaki & Chad G. Rusthoven. (2022) Association of Operability With Post-Treatment Mortality in Early-Stage Non-Small Cell Lung Cancer. Clinical Lung Cancer 23:3, pages e231-e237.
Crossref
Crossref
Aaron R. Dezube, Emanuele Mazzola, Lisa Cooper, Ashley L. Deeb, Luis E. De‐Leon, Lisa Singer, Francine L. Jacobson, Michael T. Jaklitsch & Daniel Wiener. (2022) Geographic differences in therapy for stage I non‐small‐cell lung cancer in older adults. Journal of Surgical Oncology 125:6, pages 1053-1060.
Crossref
Crossref
Yuhan Liu, Tingting Hu, Xu Li, Xiaohang Li, Jianlin Yu, Yang Wu, Simei Chen & Liming Tan. (2022) Application of collagen triple helix repeat containing‐1 and mitotic spindle apparatus antibody in small cell lung cancer diagnosis. Journal of Clinical Laboratory Analysis 36:5.
Crossref
Crossref
Tanvi Khanna, Akash Dave, Sejal Purani, Jagath Vedamurthy, Dhaval Jivani & Pushpa Robin. (2022) <i>Bauhinia variegata</i> Bark Extract: Assessment of its Anti-proliferative and Apoptotic Activities on A549 and H460 Lung Cancer Cell Lines. Journal of Natural Remedies 22:2, pages 175.
Crossref
Crossref
Sorayya Rezayi, Sharareh R Niakan Kalhori & Soheila Saeedi. (2022) Effectiveness of Artificial Intelligence for Personalized Medicine in Neoplasms: A Systematic Review. BioMed Research International 2022, pages 1-34.
Crossref
Crossref
Shideh Mirhadi, Shirley Tam, Quan Li, Nadeem Moghal, Nhu-An Pham, Jiefei Tong, Brian J. Golbourn, Jonathan R. Krieger, Paul Taylor, Ming Li, Jessica Weiss, Sebastiao N. Martins-Filho, Vibha Raghavan, Yasin Mamatjan, Aafaque A. Khan, Michael Cabanero, Shingo Sakashita, Kugeng Huo, Sameer Agnihotri, Kota Ishizawa, Thomas K. Waddell, Gelareh Zadeh, Kazuhiro Yasufuku, Geoffrey Liu, Frances A. Shepherd, Michael F. Moran & Ming-Sound Tsao. (2022) Integrative analysis of non-small cell lung cancer patient-derived xenografts identifies distinct proteotypes associated with patient outcomes. Nature Communications 13:1.
Crossref
Crossref
Gregory T. Kennedy, Feredun S. Azari, Elizabeth Bernstein, Bilal Nadeem, Ashley E. Chang, Alix Segil, Neil Sullivan, Isvita Marfatia, Azra Din, Charuhas Desphande, John C. Kucharczuk, Philip S. Low & Sunil Singhal. (2022) A Prostate-Specific Membrane Antigen—Targeted Near-Infrared Conjugate for Identifying Pulmonary Squamous Cell Carcinoma during Resection. Molecular Cancer Therapeutics 21:4, pages 546-554.
Crossref
Crossref
Yung-Shuo Kao & Jen Yang. (2022) Deep learning-based auto-segmentation of lung tumor PET/CT scans: a systematic review. Clinical and Translational Imaging 10:2, pages 217-223.
Crossref
Crossref
Emelie Gezelius, Pär-Ola Bendahl, Widet Gallo, Kelin Gonçalves de Oliveira, Lars Ek, Bengt Bergman, Jan Sundberg, Olle Melander & Mattias Belting. (2022) Circulating Levels of the Cardiovascular Biomarkers ST2 and Adrenomedullin Predict Outcome within a Randomized Phase III Lung Cancer Trial (RASTEN). Cancers 14:5, pages 1307.
Crossref
Crossref
Yun-Chieh Tu, Wei-Chen Yeh, Hsin-Hsien Yu, Yu-Cheng Lee & Bor-Chyuan Su. (2022) Hedgehog Suppresses Paclitaxel Sensitivity by Regulating Akt-Mediated Phosphorylation of Bax in EGFR Wild-Type Non-Small Cell Lung Cancer Cells. Frontiers in Pharmacology 13.
Crossref
Crossref
Astrid Bauschke, Annelore Altendorf-Hofmann, Merten Homman, Thomas Manger, Jörg Pertschy, Herry Helfritzsch, Hubert Göbel & Utz Settmacher. (2021) Surgical treatment of liver metastases from non-colorectal non-neuroendocrine carcinomas. Journal of Cancer Research and Clinical Oncology 148:2, pages 503-515.
Crossref
Crossref
Meng Li, Hui Ren, Yanpeng Zhang, Na Liu, Meng Fan, Ke Wang, Tian Yang, Mingwei Chen & Puyu Shi. (2022) MECOM/PRDM3 and PRDM16 Serve as Prognostic-Related Biomarkers and Are Correlated With Immune Cell Infiltration in Lung Adenocarcinoma. Frontiers in Oncology 12.
Crossref
Crossref
Lafi Alanazi, Ryan N Alqahtani, Nazish Masud, Meshal M Zuraie, Abdulrahman A Bin Afif & Sulaiman H Alanazi. (2022) The Role of Tissue and Liquid Biopsy in the Clinical Management of Adult Lung Cancer Patients in King Abdul-Aziz Medical City in Riyadh, Saudi Arabia. Cureus.
Crossref
Crossref
Shuqin Xing, Kaiwen Hu & Yafei Wang. (2022) Tumor Immune Microenvironment and Immunotherapy in Non-Small Cell Lung Cancer: Update and New Challenges. Aging and disease 13:6, pages 1615.
Crossref
Crossref
皓悦 王. (2022) Research on Targeting and Immunotherapy of Small Cell Lung Cancer. Advances in Clinical Medicine 12:08, pages 7005-7011.
Crossref
Crossref
Aqib H. Zehri, Keyan A. Peterson, Katriel E. Lee, Carol A. Kittel, Joni K. Evans, Jonathan L. Wilson & Wesley Hsu. (2022) National trends in the surgical management of metastatic lung cancer to the spine using the national inpatient sample database from 2005 to 2014. Journal of Clinical Neuroscience 95, pages 88-93.
Crossref
Crossref
Åslaug Helland, Klaus Kaae Andersen, Tor Åge Myklebust, Tom Børge Johannesen, Jørgen Aarøe & Espen Enerly. (2022) EGFR-mutation testing and TKI treatment patterns in locally advanced and metastatic NSCLC in Norway – A nationwide retrospective cohort study. Cancer Treatment and Research Communications 33, pages 100636.
Crossref
Crossref
Robert S. Epstein, Jerrod Nelms, Donald Moran, Cynthia Girman, Huan Huang & Marc Chioda. (2022) Treatment patterns and burden of myelosuppression for patients with small cell lung cancer: A SEER‐medicare study. Cancer Treatment and Research Communications 31, pages 100555.
Crossref
Crossref
I. Vlahos, J.J. Erasmus & M.T. Truong. (2022) Special issue on imaging the post cancer-treatment chest: heralding a new definition of an “expert thoracic imager”?. Clinical Radiology 77:1, pages 3-5.
Crossref
Crossref
Peggi M. Angel & Stephen C. Zambrzycki. 2022. Stromal Signaling in Cancer. Stromal Signaling in Cancer
15
45
.
Martin C Tammemägi, Mamta Ruparel, Alain Tremblay, Renelle Myers, John Mayo, John Yee, Sukhinder Atkar-Khattra, Ren Yuan, Sonya Cressman, John English, Eric Bedard, Paul MacEachern, Paul Burrowes, Samantha L Quaife, Henry Marshall, Ian Yang, Rayleen Bowman, Linda Passmore, Annette McWilliams, Fraser Brims, Kuan Pin Lim, Lin Mo, Stephen Melsom, Bann Saffar, Mark Teh, Ramon Sheehan, Yijin Kuok, Renee Manser, Louis Irving, Daniel Steinfort, Mark McCusker, Diane Pascoe, Paul Fogarty, Emily Stone, David C L Lam, Ming-Yen Ng, Varut Vardhanabhuti, Christine D Berg, Rayjean J Hung, Samuel M Janes, Kwun Fong & Stephen Lam. (2022) USPSTF2013 versus PLCOm2012 lung cancer screening eligibility criteria (International Lung Screening Trial): interim analysis of a prospective cohort study. The Lancet Oncology 23:1, pages 138-148.
Crossref
Crossref
Displaying 200 of 305 citing articles. Use the download link below to view the full list of citing articles.
Download full citations list